Increased levels of calprotectin have been found in several diseases, such as in rheumatoid arthritis, inflammatory bowel disease or cardiovascular diseases, indicating to be a more sensitive biomarker for diagnosis and monitoring of disease activity than C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR)7–13. This evidence concerns the gene CRP and inflammatory bowel disease.